4559:TYO
Zeria Pharmaceutical Co Ltd
JP¥ १,९१४.००
arrow_upward
+०.५८%(+११.००) 1D
अक्टोबर ६, १५:३०:०० GMT+९ · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
JP¥ १,९०३
High
JP¥ १,९१९
Low
JP¥ १,९००
Mkt. cap
९५.९३ अरब
Avg. vol.
१.७० लाख
Volume
०.००
Dividend
२.५६%
Quarterly dividend
JP¥ १२
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
१०.२५
52-wk high
JP¥ २,४३४
52-wk low
JP¥ १,८७८
EPS
JP¥ १८७
Shares outstanding
५.०१ करोड
No. of employees
२ हजार
Open
JP¥ १,९०३
High
JP¥ १,९१९
Low
JP¥ १,९००
Mkt. cap
९५.९३ अरब
Avg. vol.
१.७० लाख
Volume
०.००
Dividend
२.५६%
Quarterly dividend
JP¥ १२
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
१०.२५
52-wk high
JP¥ २,४३४
52-wk low
JP¥ १,८७८
EPS
JP¥ १८७
Shares outstanding
५.०१ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
Simply Wall Street
·
५३ मिनेट पहिले
What Does Ascendis Pharma (ASND) Gain From Its CNP Patent Settlement?
Moomoo
·
१५ मिनेट पहिले
S&P 500 and Nasdaq Hit Record Highs; Memory Chip Stocks Plunge as SK Hynix (SKHY.US) Drops Over 6%
TheStreet Pro
·
३८ मिनेट पहिले
Continued Broadening Lifts S&P 500 to First Record Since August
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd